ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

Pittsburgh Cancer Institute Gets NCI Core Grants

June 24, 1988

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002

Senate Votes To Invalidate Task Force Guideline

December 4, 2009